Bruce Cheson

Bruce Cheson

UNVERIFIED PROFILE

Are you Bruce Cheson?   Register this Author

Register author
Bruce Cheson

Bruce Cheson

Publications by authors named "Bruce Cheson"

Are you Bruce Cheson?   Register this Author

99Publications

2638Reads

44Profile Views

Targeting Biology in Non-Hodgkin Lymphoma.

Hematol Oncol Clin North Am 2019 Aug 7;33(4):727-738. Epub 2019 May 7.

Lombardi Comprehensive Cancer Center, Medstar Georgetown University Hospital, Lombardi Comprehensive Cancer Center Podium A, 3800 Reservoir Road Northwest, Washington, DC 20007, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2019.03.006DOI Listing
August 2019

Descriptive analysis of genetic aberrations and cell of origin in Richter transformation.

Leuk Lymphoma 2019 Apr 11;60(4):971-979. Epub 2019 Jan 11.

f Department of Hematology and Oncology , Lombardi Comprehensive Cancer Center Medstar Georgetown University Hospital , Washington , D.C , U.S.A.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/10428194.2018.1
Publisher Site
http://dx.doi.org/10.1080/10428194.2018.1516878DOI Listing
April 2019

Combinations or sequences of targeted agents in CLL: is the whole greater than the sum of its parts (Aristotle, 360 BC)?

Blood 2019 01 14;133(2):121-129. Epub 2018 Nov 14.

Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC; and.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/lookup/doi/10.1182/blood-2018-08
Publisher Site
http://dx.doi.org/10.1182/blood-2018-08-869503DOI Listing
January 2019

Determining the sequence of novel therapies in the treatment of relapsed Hodgkin's lymphoma.

Expert Rev Hematol 2018 10 5;11(10):773-780. Epub 2018 Sep 5.

a Lombardi Comprehensive Cancer Center , MedStar Georgetown University Hospital , Washington , DC , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2018.1516135DOI Listing
October 2018

Overall Survival Benefit in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma Who Received Obinutuzumab Plus Bendamustine Induction and Obinutuzumab Maintenance in the GADOLIN Study.

J Clin Oncol 2018 08 27;36(22):2259-2266. Epub 2018 Mar 27.

Bruce D. Cheson, Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC; Neil Chua, University of Alberta, Edmonton, Alberta; Greg Dueck, British Columbia Cancer Agency, Kelowna; Laurie H. Sehn, Centre for Lymphoid Cancer, British Columbia Cancer Agency and the University of British Columbia, Vancouver, British Columbia, Canada; Jiri Mayer, University Hospital and Masaryk University, Brno; Marek Trněný, Charles University General Hospital, Prague, Czech Republic; Kamal Bouabdallah, Centre Hospitalier Universitaire Haut-Leveque, Bordeaux; Vincent Delwail, Centre Hospitalier Universitaire de Poitiers, Poitiers; Gilles Salles, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France; Nathan Fowler, University of Texas, Houston, TX; Oliver Press, Fred Hutchinson Cancer Research Center, Seattle, WA; John G. Gribben, Queen Mary University of London, London; Anne Lennard, Newcastle University, Newcastle upon Tyne, United Kingdom; Pieternella J. Lugtenburg, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; and Günter Fingerle-Rowson, Federico Mattiello, and Andrea Knapp, F. Hoffmann-La Roche, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.76.3656
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.76.3656DOI Listing
August 2018

Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study.

J Clin Oncol 2018 08 31;36(23):2405-2412. Epub 2018 May 31.

Ajay K. Gopal, The University of Washington; Ajay K. Gopal, Fred Hutchinson Cancer Research Center, Seattle, WA; Stephen J. Schuster, Abramson Cancer Center of the University of Pennsylvania, Philadelphia; Jing-Zhou Hou, University of Pittsburgh Medical Center; Jing-Zhou Hou, University of Pittsburgh Cancer Institute, Pittsburgh; Rajendra N. Damle, Michael Schaffer, and Sriram Balasubramanian, Janssen Research & Development, Spring House, PA; Nathan H. Fowler, The University of Texas MD Anderson Cancer Center, Houston, TX; Judith Trotman, Concord Hospital, University of Sydney, Sydney, New South Wales; Andrew Spencer, Alfred Hospital-Monash University, Melbourne, Victoria; James Morton, Haematology and Oncology Clinics of Australia, Milton, Queensland, Australia; Georg Hess, Johannes Gutenberg-University, Mainz, Germany; Abdulraheem Yacoub, Kansas University Medical Center, Kansas City, KS; Michael Lill, Cedars-Sinai Medical Center, Los Angeles, CA; Peter Martin, Weill Cornell Medical College, Cornell University, New York, NY; Umberto Vitolo, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Turin, Italy; John Radford, University of Manchester; John Radford, Christie National Health Service Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom; Wojciech Jurczak, Jagiellonian University, Kraków, Poland; Dolores Caballero, Hospital Clínico Universitario, Salamanca, Spain; Sanjay Deshpande, Gary J. Gartenberg, and Shean-Sheng Wang, Janssen Research & Development, Raritan, NJ; Jessica Vermeulen, Janssen Research & Development, Leiden, the Netherlands; Bruce D. Cheson, Georgetown University Hospital, Washington, DC; and Gilles Salles, Hospices Civils de Lyon-Université de Lyon, Pierre-Bénite cedex, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.8853DOI Listing
August 2018

Surrogate Endpoints and Risk Adaptive Strategies in Previously Untreated Follicular Lymphoma.

Clin Lymphoma Myeloma Leuk 2018 07 5;18(7):447-451. Epub 2018 May 5.

Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, DC. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S21522650183003
Publisher Site
http://dx.doi.org/10.1016/j.clml.2018.04.008DOI Listing
July 2018

Speaking volumes about volumes.

Authors:
Bruce D Cheson

Blood 2018 05;131(22):2408-2409

Lombardi Comprehensive Cancer Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2018-04-841924DOI Listing
May 2018

Continued Excellent Outcomes in Previously Untreated Patients With Follicular Lymphoma After Treatment With CHOP Plus Rituximab or CHOP Plus I-Tositumomab: Long-Term Follow-Up of Phase III Randomized Study SWOG-S0016.

J Clin Oncol 2018 03 22;36(7):697-703. Epub 2018 Jan 22.

Mazyar Shadman, Ajay K. Gopal, David G. Maloney, and Oliver W. Press, University of Washington and Fred Hutchinson Cancer Research Center; Hongli Li and Michael LeBlanc, SWOG Statistical Center, Seattle, WA; Lisa Rimsza, Mayo Clinic Arizona, Scottsdale; Catherine M. Spier, University of Arizona, Tucson, AZ; John P. Leonard, Weill Cornell Medical College, New York; Jonathan W. Friedberg, Wilmot Cancer Institute, University of Rochester, Rochester, NY; Mark S. Kaminski, University of Michigan Health System, Ann Arbor, MI; Rita M. Braziel, Oregon Health & Science University, Portland, OR; Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC; Shaker Dakhil, University of Kansas School of Medicine-Wichita, Wichita, KS; Sonali M. Smith, University of Chicago Medicine, Chicago, IL; and Richard I. Fisher, Fox Chase Cancer Center and Temple University School of Medicine, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.74.5083
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.74.5083DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553811PMC
March 2018

PET/CT in Lymphoma: Current Overview and Future Directions.

Authors:
Bruce D Cheson

Semin Nucl Med 2018 01 2;48(1):76-81. Epub 2017 Oct 2.

Georgetown University Hospital, Washington, DC. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00012998173008
Publisher Site
http://dx.doi.org/10.1053/j.semnuclmed.2017.09.007DOI Listing
January 2018

What Is the Role of Chemotherapy in Patients With Chronic Lymphocytic Leukemia?

Authors:
Bruce D Cheson

Clin Lymphoma Myeloma Leuk 2017 11 12;17(11):723-727. Epub 2017 Jul 12.

Division of Hematology-Oncology, Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.06.023DOI Listing
November 2017

Overestimated value of FDG-PET based bone marrow evaluation in lymphoma: Response to Adams and Kwee.

Br J Haematol 2017 10 8;179(2):337-339. Epub 2016 Jul 8.

Lombardi Comprehensive Cancer Center, Medstar Georgetown University Hospital, Washington, DC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14216DOI Listing
October 2017

Extended Follow-up of Patients Treated With Bendamustine for Lymphoid Malignancies.

Clin Lymphoma Myeloma Leuk 2017 10 30;17(10):637-644. Epub 2017 Jun 30.

Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, DC. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S21522650173025
Publisher Site
http://dx.doi.org/10.1016/j.clml.2017.06.033DOI Listing
October 2017

Impact of obinutuzumab alone and in combination for follicular lymphoma.

Blood Lymphat Cancer 2017 19;7:73-83. Epub 2017 Oct 19.

Division of Hematology-Oncology, Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/BLCTT.S114173DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467363PMC
October 2017

Pros and cons of rituximab maintenance in follicular lymphoma.

Cancer Treat Rev 2017 Jul 16;58:34-40. Epub 2017 Jun 16.

Lombardi Comprehensive Cancer Center, Medstar Georgetown University Hospital, Washington, DC, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2017.05.007DOI Listing
July 2017

Investigator and independent review committee exploratory assessment and verification of tumor response in a non-Hodgkin lymphoma study.

Leuk Lymphoma 2017 06 10;58(6):1332-1340. Epub 2016 Oct 10.

f Division of Hematology and Oncology , Georgetown University , Washington , DC , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2016.1233535DOI Listing
June 2017

Recommendations for Clinical Trial Development in Follicular Lymphoma.

J Natl Cancer Inst 2017 03 31;109(3). Epub 2016 Dec 31.

Affiliations of authors: The Ohio State University, Columbus, OH (KM); University of Rochester Medical Center, Rochester, NY (PMB); Georgetown University Hospital, Washington, DC (BDC); Division of Cancer Treatment and Diagnosis (RFL) and Coordinating Center for Clinical Trials (LB), National Cancer Institute, Bethesda, MD; Department of Medicine, Oncology Division, Washington University, St. Louis, MO (BSK); Department of Medicine, Weil Cornell University, New York, NY (JPL); The University of Texas MD Anderson Cancer Center, Houston, TX (NF); Northwestern University, Chicago, IL (LIG); University of Iowa, Iowa City, IA (BKL); Wilmot Cancer Center and Division of Hematology/Oncology, University of Rochester, Rochester, NY (JWF); Mayo Clinic, Rochester, MN (SMA).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw255DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059137PMC
March 2017

Ibrutinib in Waldenström's macroglobulinemia: revamping the landscape.

Lancet Oncol 2017 02 10;18(2):165-166. Epub 2016 Dec 10.

Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC 20007, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(16)30623-4DOI Listing
February 2017

FDG-PET for Early Response Assessment in Lymphomas: Part 1-Hodgkin Lymphoma.

Oncology (Williston Park) 2017 01;31(1):45-9

View Article

Download full-text PDF

Source
January 2017

PI3K signaling pathway in normal B cells and indolent B-cell malignancies.

Semin Oncol 2016 Dec 17;43(6):647-654. Epub 2016 Nov 17.

Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2016.11.011DOI Listing
December 2016

Letter From the Editor: The end.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2016 Dec;14(12):942

Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
December 2016

Letter From the Editor: Ode to Bob.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2016 Nov;14(11):838

Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
November 2016

Letter From the Editor: Fellowship interviews and more.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2016 Oct;14(10):742

Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
October 2016

Letter From the Editor: From 2003 to today.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2016 Sep;14(9):646

Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
September 2016

(18) F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphoma.

Br J Haematol 2016 08 20;174(3):410-6. Epub 2016 Apr 20.

Lombardi Comprehensive Cancer Center, Medstar Georgetown University Hospital, Washington, DC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14071DOI Listing
August 2016

Letter from the editor: the campaign button.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2016 Aug;14(8):566

Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
August 2016

Speed bumps on the road to a chemotherapy-free world for lymphoma patients.

Authors:
Bruce D Cheson

Blood 2016 07 24;128(3):325-30. Epub 2016 May 24.

Lombardi Comprehensive Cancer Center, Medstar Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-04-709477DOI Listing
July 2016

Letter From the Editor: When will we ever learn?

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2016 Jul;14(7):461

Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
July 2016

US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.

J Clin Oncol 2016 06 11;34(17):2020-7. Epub 2016 Apr 11.

Oliver W. Press, Fred Hutchinson Cancer Research Center, and the University of Washington; Hongli Li and Michael LeBlanc, Fred Hutchinson Cancer Research Center, Seattle, WA; Heiko Schöder, David J. Straus, Craig H. Moskowitz, and Ariela Noy, Memorial Sloan Kettering Cancer Center; John P. Leonard, Weill Cornell Medical College and New York Presbyterian Hospital, New York City; Paul M. Barr and Jonathan W. Friedberg, University of Rochester Medical Center, Rochester, NY; Lisa M. Rimsza, University of Arizona, Tucson, AZ; Nancy L. Bartlett and Brad S. Kahl, Washington University School of Medicine, St. Louis, MO; Andrew M. Evens, Tufts Medical Center; Ann S. LaCasce, Dana-Farber Cancer Institute, Boston, MA; Erik S. Mittra, Stanford University Medical Center, Stanford, CA; John W. Sweetenham, Huntsman Cancer Hospital, Salt Lake City, UT; Michelle A. Fanale, University of Texas MD Anderson Cancer Center, Houston, TX; Michael V. Knopp, The Ohio State University, Columbus; Eric D. Hsi, Cleveland Clinic Foundation; James R. Cook, Cleveland Clinic, Cleveland, OH; Mary Jo Lechowicz, Winship Cancer Institute of Emory University, Atlanta, GA; Randy D. Gascoyne, British Columbia Cancer Agency, Vancouver, BC; Bruce D. Cheson, Georgetown University Hospital, Washington DC; and Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.1119DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966513PMC
June 2016

Letter From the Editor: When Breath Becomes Air.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2016 Jun;14(6):382

Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
June 2016

Letter From the Editor: The pedant and the scoundrel.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2016 May;14(5):286

Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
May 2016

The role of idelalisib in the treatment of relapsed and refractory chronic lymphocytic leukemia.

Ther Adv Hematol 2016 Apr 3;7(2):69-84. Epub 2016 Feb 3.

Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, 3800 Reservoir Road NW, Washington, DC 20007, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620715625966DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802506PMC
April 2016

Letter From the Editor: Moonshot medicine.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2016 Apr;14(4):198

Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
April 2016

Letter From the Editor: Doctors as writers.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2016 Mar;14(3):143

Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
March 2016

Letter From the Editor: I love boobies.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2016 Feb;14(2):72

Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
February 2016

What is the status of novel anti-CD20 antibodies for chronic lymphocytic leukemia and are they set to leave rituximab in the shadows?

Expert Rev Hematol 2015 Dec 14;8(6):733-42. Epub 2015 Sep 14.

b 2 Medstar Georgetown University Hospital, Washington DC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474086.2015.1087844DOI Listing
December 2015

Letter From the Editor: A thankful end of the year.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2015 Dec;13(12):787

Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
December 2015

Randomized Trial of Lenalidomide Alone Versus Lenalidomide Plus Rituximab in Patients With Recurrent Follicular Lymphoma: CALGB 50401 (Alliance).

J Clin Oncol 2015 Nov 24;33(31):3635-40. Epub 2015 Aug 24.

John P. Leonard, Meyer Cancer Center, Weill Cornell Medical College and New York Presbyterian Hospital, New York; Myron Czuczman, Roswell Park Cancer Institute, Buffalo, NY; Sin-Ho Jung, Jeffrey Johnson, and Brandelyn N. Pitcher, Alliance Statistics and Data Center, Duke University, Durham, NC; Nancy L. Bartlett, Washington University School of Medicine, St Louis, MO; Kristie A. Blum, Ohio State University Medical Center, Columbus, OH; Jeffrey K. Giguere, Greenville Community Clinical Oncology Program, Greenville, SC; and Bruce D. Cheson, Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/08/21/JCO.2014.59
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.59.9258
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.59.9258DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622102PMC
November 2015

Letter From the Editor: For what it's worth.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2015 Nov;13(11):695

Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
November 2015

Letter From the Editor: Interviewing season.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2015 Oct;13(10):621

Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
October 2015

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.

Authors:
Ayalew Tefferi Hagop Kantarjian S Vincent Rajkumar Lawrence H Baker Jan L Abkowitz John W Adamson Ranjana Hira Advani James Allison Karen H Antman Robert C Bast John M Bennett Edward J Benz Nancy Berliner Joseph Bertino Ravi Bhatia Smita Bhatia Deepa Bhojwani Charles D Blanke Clara D Bloomfield Linda Bosserman Hal E Broxmeyer John C Byrd Fernando Cabanillas George Peter Canellos Bruce A Chabner Asher Chanan-Khan Bruce Cheson Bayard Clarkson Susan L Cohn Gerardo Colon-Otero Jorge Cortes Steven Coutre Massimo Cristofanilli Walter J Curran George Q Daley Daniel J DeAngelo H Joachim Deeg Lawrence H Einhorn Harry P Erba Francisco J Esteva Elihu Estey Isaiah J Fidler James Foran Stephen Forman Emil Freireich Charles Fuchs James N George Morie A Gertz Sergio Giralt Harvey Golomb Peter Greenberg Jordan Gutterman Robert I Handin Samuel Hellman Paulo Marcelo Hoff Ronald Hoffman Waun Ki Hong Mary Horowitz Gabriel N Hortobagyi Clifford Hudis Jean Pierre Issa Bruce Evan Johnson Philip W Kantoff Kenneth Kaushansky David Khayat Fadlo R Khuri Thomas J Kipps Margaret Kripke Robert A Kyle Richard A Larson Theodore S Lawrence Ross Levine Michael P Link Scott M Lippman Sagar Lonial Gary H Lyman Maurie Markman John Mendelsohn Neal J Meropol Yoav Messinger Therese M Mulvey Susan O'Brien Roman Perez-Soler Raphael Pollock Josef Prchal Oliver Press Jerald Radich Kanti Rai Saul A Rosenberg Jacob M Rowe Hope Rugo Carolyn D Runowicz Brenda M Sandmaier Alan Saven Andrew I Schafer Charles Schiffer Mikkael A Sekeres Richard T Silver Lillian L Siu David P Steensma F Marc Stewart Wendy Stock Richard Stone Rainer Storb Louise C Strong Martin S Tallman Michael Thompson Naoto T Ueno Richard A Van Etten Julie M Vose Peter H Wiernik Eric P Winer Anas Younes Andrew D Zelenetz Charles A LeMaistre

Mayo Clin Proc 2015 Aug 23;90(8):996-1000. Epub 2015 Jul 23.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2015.06.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365030PMC
August 2015

Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108.

J Clin Oncol 2015 Jul 15;33(21):2399-404. Epub 2015 Jun 15.

Paul M. Barr and Jonathan W. Friedberg, University of Rochester, Rochester; Steven M. Horwitz, Memorial Sloan Kettering Cancer Center, New York, NY; Hongli Li and Michael LeBlanc, SWOG Statistical Office, Seattle, WA; Catherine Spier, University of Arizona College of Medicine, Tucson, AZ; Daruka Mahadevan, Mansoor Ul Haq, and Bryan D. Huber, University of Tennessee Health Sciences Center, Memphis, TN; Christopher R. Flowers, Emory University, Atlanta, GA; Nina D. Wagner-Johnston and Nancy L. Bartlett, Washington University School of Medicine, St. Louis, MO; Richard I. Fisher, Temple University, Philadelphia, PA; Bruce D. Cheson, Georgetown University Hospital, Washington, DC; Sonali M. Smith, The University of Chicago, Chicago, IL; and Brad S. Kahl, University of Wisconsin, Madison, WI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.6327DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500834PMC
July 2015

Letter From the Editor: Reflections on Lugano.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2015 Jul;13(7):409

Department of Hematology/Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, District of Columbia.

View Article

Download full-text PDF

Source
July 2015

Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 Trial.

J Clin Oncol 2015 Jun 20;33(17):1936-42. Epub 2015 Apr 20.

Ranjana H. Advani, Richard T. Hoppe, and Sandra J. Horning, Stanford University, Stanford; Joseph M. Tuscano, University of California, Davis Cancer Center, Sacramento, CA; Fangxin Hong, Dana-Farber Cancer Institute, Boston, MA; Richard I. Fisher and Jonathan W. Friedberg, University of Rochester, Rochester, NY; Nancy L. Bartlett, Washington University School of Medicine, St Louis, MO; K. Sue Robinson, Queen Elizabeth II Health Science Center, Halifax, Nova Scotia; Randy D. Gascoyne, British Columbia Cancer Agency, Vancouver, British Columbia; Douglas A. Stewart, Tim Baker Cancer Institute, Calgary, Alberta, Canada; Henry Wagner Jr, Penn State Cancer Institute, Hershey, PA; Patrick J. Stiff, Loyola University Medical Center, Maywood; Leo I. Gordon, Northwestern University, Chicago, IL; Bruce D. Cheson, Georgetown University Hospital, Washington, DC; Brad S. Kahl, University of Wisconsin, Madison, WI; Kristie A. Blum, Ohio State University, Columbus, OH; and Thomas M. Habermann, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/04/15/JCO.2014.57
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.57.8138
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.57.8138DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451176PMC
June 2015

Rethinking clinical response and outcome assessment in a biologic age.

Authors:
Bruce D Cheson

Curr Oncol Rep 2015 Jun;17(6):27

Hematology-Oncology, Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC, 20007, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-015-0452-2DOI Listing
June 2015

The "ASC(ST)O" meeting.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2015 Jun;13(6):341

Department of Hematology/Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, District of Columbia.

View Article

Download full-text PDF

Source
June 2015

A phase I study of bendamustine, lenalidomide and rituximab in relapsed and refractory lymphomas.

Br J Haematol 2015 May 7;169(4):528-33. Epub 2015 Mar 7.

Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13321DOI Listing
May 2015

Letter From the Editor: The return of the emperor.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2015 May;13(5):271

Department of Hematology/Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, District of Columbia.

View Article

Download full-text PDF

Source
May 2015

Small molecules, big challenges.

Authors:
Bruce D Cheson

Oncology (Williston Park) 2015 Apr;29(4):308-c3

View Article

Download full-text PDF

Source
April 2015

Letter From the Editor: Inside my file cabinets.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2015 Apr;13(4):203

Department of Hematology/Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, District of Columbia.

View Article

Download full-text PDF

Source
April 2015

Lymphoma: looking from the present to the future.

Chin Clin Oncol 2015 Mar;4(1)

Professor of Medical Oncology, Chief, Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing 100142, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2304-3865.2015.03.06DOI Listing
March 2015

Staging and response assessment in lymphomas: the new Lugano classification.

Authors:
Bruce D Cheson

Chin Clin Oncol 2015 Mar;4(1)

Division of Hematology/Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington DC 20007, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2304-3865.2014.11.03DOI Listing
March 2015

Letter From the Editor: Lies and truth.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2015 Mar;13(3):140

Department of Hematology/Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, District of Columbia.

View Article

Download full-text PDF

Source
March 2015

The creative destruction of medicine.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2015 Jan;13(1):12

Department of Hematology/Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, District of Columbia.

View Article

Download full-text PDF

Source
January 2015

The creative destruction of medicine.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2015 Jan;13(1):12

Department of Hematology/Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, District of Columbia.

View Article

Download full-text PDF

Source
January 2015

Is ebola scarier than cancer?

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2014 Nov;12(11):718

Department of Hematology/Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, District of Columbia.

View Article

Download full-text PDF

Source
November 2014

PET-CT restaging: a surrogate for follicular lymphoma?

Authors:
Bruce D Cheson

Lancet Haematol 2014 Oct 17;1(1):e2-3. Epub 2014 Sep 17.

Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC 20007, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(14)70015-8DOI Listing
October 2014

The interviewing of the fellows.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2014 Oct;12(10):636

Department of Hematology/Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, District of Columbia.

View Article

Download full-text PDF

Source
October 2014

Clinical Advances in Hematology & Oncology. Letter from the editor.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2014 Sep;12(9):558

Department of Hematology/Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, District of Columbia.

View Article

Download full-text PDF

Source
September 2014

Highlights from the 2014 Congress of the European Hematology Association.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2014 Sep;12(9):619-22

Department of Hematology/Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, District of Columbia.

View Article

Download full-text PDF

Source
September 2014

Letter from the editor.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2014 Aug;12(8):496

Department of Hematology/Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, District of Columbia.

View Article

Download full-text PDF

Source
August 2014

Letter from the Editor.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2014 Jul;12(7):422

Department of Hematology/Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, District of Columbia.

View Article

Download full-text PDF

Source
July 2014